Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Glaxo presents new NNRTI from quinoxaline class that has progressed to human trials

Feb. 12, 1999

Steroidogenesis Inhibitors to begin satellite open clinical studies in multiple indications

Feb. 12, 1999

Sarawak MediChem's calanolide compounds featured at ROI conference

Feb. 11, 1999

Facilitated DNA plasmid vaccine construct induces immune responses in HIV+ subjects

Feb. 11, 1999

BCH-10652: structure and first clinical data presented at AIDS conference

Feb. 11, 1999

Aronex further defines mechanism of action of AR-177

Feb. 11, 1999

New polycarboxamides with multiple pharmacological actions developed at Pharmacia & Upjohn

Feb. 11, 1999

NIAID opens phase I trial of vCP205 in Uganda

Feb. 10, 1999

Lexigen's HIV fusion inhibitor is safe and effective in phase II trial

Feb. 10, 1999

Anti-CMV MAb slows disease progression in AIDS patients

Feb. 10, 1999